MedicalResearch.com Interview with:
Ian Gilron, MD, MSc, FRCPC
Director of Clinical Pain Research
Professor of Anesthesiology & Perioperative Medicine,
Biomedical & Molecular Sciences, and
Center for Neuroscience Studies Queen's University
Kingston General Hospital, Kingston, Ontario, Canada
Medical Research: What are the main findings of the study?
Dr. Gilron: Pain is the most common symptom which prevents recovery from surgery. Even with the best available treatments today, many patients still suffer from moderate to severe pain after surgery.
Antidepressants - drugs used to treat depression - are also proven effective for treating chronic pain due to nerve disease and fibromyalgia. However, there has been much less research on the effects of antidepressant drugs on pain after surgery.
Our group conducted a systematic review of all published clinical trials of antidepressant for post surgical pain.
Slightly more than half of these studies suggested some benefit of these drugs but the details of this review led us to conclude that there is not yet enough evidence to recommend these medications for post surgical pain treatment.
Given the possibility that these medications could be useful treatments for pain after surgery, we believe that future studies of higher scientific quality and which involve larger numbers of patients should be carried out in the hopes of finding safer and more effective treatments for pain after surgery.
MedicalResearch.com Interview with:
Prof. Peter B. Marko
Department of Biology
University of Hawaii at Mānoa,
Honolulu, Hawaii
Medical Research: What are the main findings of the study
Prof. Marko: The main finding of the study was that species substitutions and fishery stock substitutions together obscure a complex pattern of mercury contamination in Chilean sea bass (or Patagonian toothfish) that can put consumers unknowingly at risk of ingesting greater levels of mercury than the labeling would suggest. Although it is well appreciated that mercury levels vary dramatically among different species of fish, and that species substitutions have the potential to expose consumers to unwanted mercury, our study shows that for Chilean sea bass, fish mislabeled as to their country or region of origin (but labeled as the correct species) have a high potential to expose consumers to unexpectedly high levels of mercury.
David Walega, MD
Chief of the Division of Pain Medicine
Northwestern Memorial Hospital and
Northwestern University Feinberg School of Medicine.
MedicalResearch.com: What are the main findings of the study?
Dr. Walega: Patients who underwent a single stellate ganglion injection with a local anesthetic had a 50% decrease in moderate -to- very severe hot flashes and this effect appeared to last thru the 6 month duration of the study; the placebo or "sham control" group had injections of saline and they did not demonstrate long-term improvements in hot flash symptoms
MedicalResearch.com Interview with:
Ru-Rong Ji, PhD
Professor, Chief of Pain Research
Department of Anesthesiology and Neurobiology
Duke University Medical Center
Durham, NC 27710
Neuroprotectin/Protectin D1 protects neuropathic pain in mice after nerve trauma
MedicalResearch.com: What are the main findings of the study?
Answer: We found the pro-resolution lipid mediator protectin D1 (PD1), derived from the fish oil DHA, can effectively prevent nerve injury-induced neuropathic pain. This treatment can also prevent nerve injury-induced neuroinflammation in the spinal cord (such as glial activation and expression of cytokines and chemokines, e.g., IL-1b, CCL2). These cytokines and chemokines are known to elicit pain.
MedicalResearch.com eInterview with Satya Krishna Ramachandran MD FRCA Director, Quality Assurance Department of Anesthesiology University of Michigan MedicalResearch.com: What are the main findings of the study? Answer: Background: A cardiac arrest is a life-threatening condition where the heart has stopped beating. This remains one of the biggest fears of patients undergoing anesthesia and surgery. This is a...